Joe Wiley, CEO of Amryt Pharma talks through their record FY 2020 Results
Episode 147, Mar 05, 2021, 02:17 PM
Joe Wiley, CEO of Amryt Pharma #AMYT talks through their record FY 2020 Results which saw 18.5% YoY revenue growth to $182.6M
Joe Wiley, CEO of Amryt Pharma #AMYTÂ talks through their record FY 2020 Results which saw 18.5% YoY revenue growth to $182.6M
Amryt is a global commercial-stage biopharmaceutical company focused on acquiring, developing and commercializing innovative treatments to help improve the lives of patients with rare and orphan diseases. Amryt comprises a strong and growing portfolio of commercial and development assets.